Perspective Therapeutics, Inc.CATXNYSE
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+155.3%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+155.3%/yr
vs -3.6%/yr prior
Acceleration
+158.9pp
Accelerating
Percentile
P100
Near historical high
vs 3Y Ago
16.6x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 397.43% |
| Q3 2025 | -15.90% |
| Q2 2025 | -10.11% |
| Q1 2025 | 51.47% |
| Q4 2024 | -141.41% |
| Q3 2024 | -30.65% |
| Q2 2024 | -9.67% |
| Q1 2024 | -66.60% |
| Q4 2023 | 25.90% |
| Q3 2023 | 7.39% |
| Q2 2023 | -1.51% |
| Q1 2023 | -249.83% |
| Q4 2022 | 23.88% |
| Q3 2022 | -99.81% |
| Q2 2022 | -74.48% |
| Q1 2022 | 26.18% |
| Q4 2021 | 28.10% |
| Q3 2021 | -108.05% |
| Q2 2021 | -42.69% |
| Q1 2021 | 12.26% |
| Q4 2020 | -22.27% |
| Q3 2020 | 39.95% |
| Q2 2020 | -116.97% |
| Q1 2020 | 39.31% |
| Q4 2019 | -8.01% |
| Q3 2019 | 26.92% |
| Q2 2019 | 1.63% |
| Q1 2019 | 18.61% |
| Q4 2018 | 5.86% |
| Q3 2018 | 35.95% |
| Q2 2018 | -77.00% |
| Q1 2018 | 8.79% |
| Q4 2017 | 5.41% |
| Q3 2017 | 16.69% |
| Q2 2017 | -34.13% |
| Q1 2017 | 6.09% |
| Q4 2016 | 6.10% |
| Q3 2016 | -25.61% |
| Q2 2016 | 5.51% |
| Q1 2016 | 5.92% |